Disclaimer

The alfapump® system is currently not approved in Canada for commercial use. DSR® therapy is still in development and is currently not approved in the United States or Canada. Any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. Sequana Medical makes no claims of safety or effectiveness of the DSR® therapy in the U.S. or Canada. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe, the United States or Canada.

Save the date Registration
Shareholders’ Club
Sequana Medical
25 June 2025

Registratie Shareholders' Club Sequana Medical

Datum:
Woensdag 25 juni 2025
Tijd:
17:30
Locatie:
Office Sequana Medical,
Kortrijksesteenweg 1112/bus 102,
9051 Sint-Denijs-Westrem (Gent)
Belangrijk:
De presentatie zal in het Nederlands plaatsvinden.




    Na registratie ontvangt u een bevestigingsmail.